Importantly, these findings have not only provided a better understanding of the role of IL-11 in breast cancer bone metastasis but also laid a foundation for future investigations to address therapeutic targeting of IL-11 for treating and preventing breast cancer induced osteolysis. Here, IL11 is linked to breast carcinoma.